00:00
00:00
00:00
ValiRx - Final Results

ValiRx Plc, the life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision medicines towards commercialisation and partnering, today announces its final results for the year ended 31 December 2017.

Oliver de Giorgio-Miller
Non-Executive Chairman

Company Events - VALIRX PLC